Evidence map›Paper›PMID 37240444›Full record

ArticleInternational journal of molecular sciences2023

Olga Y Timoshina, Anastasia A Kasimova, Mikhail M Shneider, Ilya O Matyuta, Alena Y Nikolaeva, Peter V Evseev, Nikolay P Arbatsky, Alexander S Shashkov, Alexander O Chizhov, Andrey A Shelenkov and 7 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Genomic landscape of 340 virulent Acinetobacter bacteriophages reveals anti-CRISPR-enriched candidates for therapeutic prioritization.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  2. Article
  3. Synergy antibacterial effects of lytic phage vB_AbaA_LLY and levofloxacin against KL2 and KL160 Acinetobacter baumannii.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  4. Advances in phage therapy forFrontiers in microbiology · 2026
    Review
  5. Bacteriophages targetingFrontiers in microbiology · 2026
    Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Lytic Capsule-SpecificViruses · 2024
    Article
  13. NewInternational journal of molecular sciences · 2024
    Article
  14. Article
  15. Article
  16. Phage-encoded depolymerases as a strategy for combating multidrug-resistantFrontiers in cellular and infection microbiology · 2024
    Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Olga Y TimoshinaShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia.ORCID 0000-0001-8727-9734
Anastasia A KasimovaN. D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, 119991 Moscow, Russia.
Mikhail M ShneiderShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia.ORCID 0000-0002-3768-3541
Ilya O MatyutaBach Institute of Biochemistry, Research Centre of Biotechnology of the Russian Academy of Sciences, 119071 Moscow, Russia.ORCID 0000-0002-6297-8392
Alena Y NikolaevaComplex of NBICS Technologies, National Research Center "Kurchatov Institute", 123182 Moscow, Russia.
Peter V EvseevShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia.ORCID 0000-0002-1646-9802
Nikolay P ArbatskyN. D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, 119991 Moscow, Russia.
Alexander S ShashkovN. D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, 119991 Moscow, Russia.
Alexander O ChizhovN. D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, 119991 Moscow, Russia.
Andrey A ShelenkovCentral Scientific Research Institute of Epidemiology, 111123 Moscow, Russia.ORCID 0000-0002-7409-077X
Yulia V MikhaylovaCentral Scientific Research Institute of Epidemiology, 111123 Moscow, Russia.ORCID 0000-0001-6779-726X
Pavel V SlukinState Research Center for Applied Microbiology and Biotechnology, 142279 Obolensk, Russia.
Nikolay V VolozhantsevState Research Center for Applied Microbiology and Biotechnology, 142279 Obolensk, Russia.
Konstantin M BoykoBach Institute of Biochemistry, Research Centre of Biotechnology of the Russian Academy of Sciences, 119071 Moscow, Russia.ORCID 0000-0001-8229-189X
Yuriy A KnirelN. D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, 119991 Moscow, Russia.
Konstantin A MiroshnikovShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia.ORCID 0000-0002-4468-4091
Anastasia V PopovaState Research Center for Applied Microbiology and Biotechnology, 142279 Obolensk, Russia.ORCID 0000-0003-0065-6459

Funding

Ministry of Science and Higher Education of the Russian Federation 075-15-2019-1671Ministry of Science and Higher Education of the Russian Federation 075-15-2021-1354Russian Science Foundation 19-14-00273Russian Science Foundation 20-75-10113
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Acinetobacter baumanniiBacteriophagesMothsAnimalsAnti-Bacterial AgentsLarvaAnti-Bacterial AgentsAcinetobacter baumanniibacteriophagecapsular polysaccharidecapsular typecrystal structureglycosidasetailspike depolymerase

Identifiers

PMID37240444
PMCPMC10219094

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.